Otros idiomas Gland Pharma Limited Bombay S.E.

Acciones

GLAND

INE068V01023

Mercado cerrado - Bombay S.E. Otros sitios de cotización 12:00:47 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1.709 ^INR	+1,02 %		+1,48 %	-11,17 %

07/05	Gland Pharma obtiene la aprobación de la FDA estadounidense para un medicamento genérico contra la ELA	MT
07/05	Gland Pharma obtiene la aprobación de la FDA estadounidense para su inyección genérica de plerixafor	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Gland Pharma Gets US FDA's Approval for Generic ALS Drug	07/05
Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection	07/05
KKR to buy India's Healthium Medtech at $839 million valuation, sources say	06/05
Gland Pharma Names COO	29/04
Gland Pharma Limited Approves Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer, Effective May 1 ,2024	29/04
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges	29/04
Gland Pharma Receives Approval for Cetrorelix Acetate for Injection	29/04
Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals	08/04
Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection	08/04
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Eribulin Mesylate Injection 0.5 Mg/ML Single Dose Vial	06/04
Gland Pharma COO, Chief Technical Officer Step Down	25/03
Gland Pharma Limited Announces Change in Management	25/03
Gland Pharma Names New President of Phixen Subsidiary	27/02
Gland Pharma's Consolidated Profit Drops in Fiscal Q3	15/02
Gland Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Indian shares set to open lower as hot US inflation spurs rate worries	14/02
Gland Pharma Gets Establishment Inspection Report from US FDA for Pashamylaram Unit	24/11
32,656,565 Equity Shares of Gland Pharma Limited are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	18/11
Gland Pharma Gets US FDA's Tentative Approval for Generic Hypotension Drug	15/11
Gland Pharma Limited Receives Tentative Approval for Angiotensin II Injection	15/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Gland Pharma Limited Bombay S.E.

Acciones

GLAND

INE068V01023

Otros idiomas

Filtros